Galimedix Therapeutics Inc.
- Address
- 3704 Calvend Lane
Sponsor Overview
Specializations
Ophthalmology
Galimedix Therapeutics Inc. is focused on clinical research in ophthalmology, with attention to degenerative retinal disease and structural preservation of the eye.
- Retinal disorders
- Vision-threatening disease
- Age-related eye disease
The sponsor’s current clinical activity is centered on conditions affecting the retina and the progression of macular degeneration.
Geographic Atrophy
Its research landscape includes geographic atrophy, particularly non-foveal geographic atrophy associated with non-neovascular age-related macular degeneration.
- Geographic atrophy lesion progression
- Non-neovascular AMD
- Retinal degeneration
Clinical interest is directed toward slowing changes in GA lesion size and addressing advanced dry age-related macular degeneration.
Ocular Therapeutics
The sponsor is engaged in development of ophthalmic solutions for local treatment of retinal pathology, with emphasis on eye-targeted therapy.
- Topical ocular treatment
- Retina-directed therapy
- Visual function preservation
Its therapeutic focus includes interventions intended for patients with progressive retinal atrophy and related ocular disease.
Clinical Research in Macular Disease
Galimedix Therapeutics Inc. is active in clinical research on macular disease, particularly disorders that affect the central retina and surrounding non-foveal regions.
- Macular pathology
- Retinal imaging endpoints
- Disease progression monitoring
Its funded trial activity reflects interest in dry age-related macular degeneration and the clinical burden of progressive retinal atrophy.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Efficacy and Safety Evaluation of GAL-101 Ophthalmic Solution in Non-Foveal Geographic Atrophy Secondary to Non-Neovascular Age-Related Macular Degeneration |  France Germany Ireland Italy | Recruiting |
Data & Insights
This sponsor works with 1 molecule, of which 1 is not being studied by other sponsors.
This sponsor has worked with 17 sites across their trial portfolio.
Therapeutic Focus
- 1.Eye Diseases1 trial138 other sponsors
Partnered Research Centres
17 centres- Address
- 433 Rue Paradis, 13008 Marseille
- Address
- 113 Boulevard Saint-Germain, 75006 Paris
- Address
- 6 rue Thérèse et René Planiol, 37540 Saint-Cyr-Sur-Loire
- Address
- 103 Grande Rue De La Croix Rousse, 69317 Lyon
- Address
- Salvador-Allende-Strasse 30, Oststadt, 17036 Neubrandenburg
- Address
- Via Di Santo Stefano Rotondo 6, 00184 Rome
Want to get in touch with this sponsor?
Send a question and we'll pass it on to Galimedix Therapeutics Inc..
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.